The report provides in depth market analysis, information and insights into the insurance industry in Benin, including:
The Beninese insurance industry’s growth prospects by insurance segments and categories
The competitive landscape in the Beninese insurance industry
The current trends and drivers of the Beninese insurance industry
The challenges facing the Beninese insurance industry
The regulatory framework of the Beninese insurance industry
Summary
Benin has a small insurance industry, indeed the nation’s population is only 9 million strong. There were 12 insurers operating in the country in 2011 and as its economy is largely dependent on exports, these firms were indirectly affected by the global financial crisis. This led to a decline in the marine, aviation and transit insurance category. Insurance penetration as a percentage of GDP is low when compared to many developed countries. The Beninese insurance industry comprises both domestic and foreign insurance companies. The government’s liberalization policy abolished the regulatory barrier, which encouraged companies such as Allianz to enter the market.
Scope
This report provides a comprehensive analysis of the insurance industry in Benin:
It provides historical values for the Beninese insurance industry for the report’s 2008–2012 review period and forecast figures for the 2012–2017 forecast period
It offers a detailed analysis of the key segments and categories in the Beninese insurance industry, along with industry forecasts until 2017
It covers an exhaustive list of parameters, including written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, total assets, total investment income and retentions
It profiles the top insurance companies in Benin and outlines the key regulations affecting them
Reasons To Buy
Make strategic business decisions using in depth historic and forecast industry data related to the Beninese insurance industry and each segment within it
Understand the demand-side dynamics, key market trends and growth opportunities within the Beninese insurance industry
Assess the competitive dynamics in the Beninese insurance industry
Identify the growth opportunities and market dynamics within key segments
Gain insights into key regulations governing the Beninese insurance industry and its impact on companies and the industry''s future
Key Highlights
Benin has a small insurance industry, indeed the nation’s population is only 9 million strong.
There were 12 insurers operating in the country in 2011 and as its economy is largely dependent on exports, these firms were indirectly affected by the global financial crisis.
This led to a decline in the marine, aviation and transit insurance category.
Insurance penetration as a percentage of GDP is low when compared to many developed countries.
The Beninese insurance industry comprises both domestic and foreign insurance companies.
The government’s liberalization policy abolished the regulatory barrier, which encouraged companies such as Allianz to enter the market.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=219409.
Contact sales@reportsandreports.com for further information.
Tuesday, 12 February 2013
Thursday, 7 February 2013
Market Overview of Hemophilia Industry - Therapeutic Class Report
Hemophilia is an inherited (X-linked recessive trait), lifelong bleeding disorder that prevents blood from clotting due to insufficient or lack of adequate amount of clotting factors – Factor VIII (FVIII) and Factor IX (proteins in blood that control bleeding). Plasma-derived FVIII and FIX proteins were used in the 70’s for treating these disorders but transmission of contaminating viruses reduced its use. In 1999, recombinant FVIIIs and FIX, free of viral, animal, or human proteins became the standard of care (SoC). However, frequent injections used for prophylaxis resulted in development of antibodies (called inhibitors – acquired hemophilia or neutralizing abs) to FVIII or FIX. The presence of inhibitors complicated treatment of hemophilia A and B- ~30% in hemophilia A and up to 3 to 5% in hemophilia B pts. The high cost of treatment, frequent dosing, and infusion related adverse events are other concerns.
To address these limitations, companies are developing next generation clotting factors which are more potent – Short Acting or Long Acting Recombinant Factors. These potentially could result in fewer injections, reduce the inhibitor level, and improve compliance. Several of these pipeline products are now poised for approval and launch in the next two-three years. At present, Baxter, Bayer/ CSL, Pfizer, Novo Nordisk dominate the current ~$10b hemophilia market. In this report, we have analyzed the clinical efficacy, safety, and commercial prospects of the late-stage products in development and expect the long acting products that have best clinical and safety data to lead by offering patients better Cost per Quality Adjusted Life Year (QALY).
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218460.
Table of Contents
1. Executive Summary
2. Next Generation Recombinant FVIIIs and FIX
2.1 Short-acting or ‘Me-Too’ Recombinants
2.1.1 Hemophilia A: Late Stage Pipeline
a Turoctocog alfa
b BAY 81-8973
c Human-cl rhFVIII
2.1.2 Hemophilia B: Late Stage Pipeline
a BAX 326
b IB1001
2.2 Long-acting Recombinants
2.2.1 Modification used for extension of half-life of proteins
(PEGylation, Fc fusion, Genetic mutation, Novel single chain)
2.2.2 Hemophilia A: Late Stage Pipeline
a rFVIIIFc
b N8-GP
c BAY 94-9027
d CSL 627
e BAX 855
2.2.3 Hemophilia B: Late Stage Pipeline
a rFIXFc
b N9-GP
c CSL 654
2.3 Hemophilia with Inhibitors – Late Stage Pipeline
a BAY 86-6150
b CSL 689
c OBI-1
d BAX 817
e PF-05280602
f NecLip-rFVIIa
3. Novel Approaches for Hemophilia and Acquired Hemophilia
3.1 Gene Therapy
3.2 Tissue Factor Pathway Inhibitor (TFPI)
4. Biosimilar Development – A Safer Bet?
5. Market Forecast
5.1 Hemophilia A
5.2 Hemophilia B
5.3 Bypass Therapies – Hemophilia with Inhibitors
6. Current Marketed Therapies
6.1 FVIII Recombinants
a ADVATE
b Kogenate FS/ Helixate FS
c Xyntha
6.2 FIX Recombinants
a BeneFIX
6.3 Hemophilia with Inhibitors
6.3.1 Detection and Quantification
6.3.2
Treatment for Hemophilia with Inhibitors
(High-Dose Clotting Factor Concentrates, Bypassing Agents, Immune
Tolerance Induction – ITI Therapy)
6.3.3 Bypassing Agents
a NovoSeven / NovoSeven RT
b FEIBA
7. Cost of Treatment And Insurance
8. Hemophilia – About The Disease, Global Epidemiology, and
Acquired Hemophilia
8.1 Types of Hemophilia
8.2 Classification/ Severity of Disease
8.3 Acquired Hemophilia
8.4 Global Epidemiology
8.5 Mortality/Morbidity
8.6 Pathophysiology
8.7 Diagnosis
8.8 Treatment / Management
8.8.1 Prophylaxis
8.8.2 Episodic / On-Demand Therapy
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218460.
Contact sales@reportsandreports.com for further information.
To address these limitations, companies are developing next generation clotting factors which are more potent – Short Acting or Long Acting Recombinant Factors. These potentially could result in fewer injections, reduce the inhibitor level, and improve compliance. Several of these pipeline products are now poised for approval and launch in the next two-three years. At present, Baxter, Bayer/ CSL, Pfizer, Novo Nordisk dominate the current ~$10b hemophilia market. In this report, we have analyzed the clinical efficacy, safety, and commercial prospects of the late-stage products in development and expect the long acting products that have best clinical and safety data to lead by offering patients better Cost per Quality Adjusted Life Year (QALY).
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218460.
Table of Contents
1. Executive Summary
2. Next Generation Recombinant FVIIIs and FIX
2.1 Short-acting or ‘Me-Too’ Recombinants
2.1.1 Hemophilia A: Late Stage Pipeline
a Turoctocog alfa
b BAY 81-8973
c Human-cl rhFVIII
2.1.2 Hemophilia B: Late Stage Pipeline
a BAX 326
b IB1001
2.2 Long-acting Recombinants
2.2.1 Modification used for extension of half-life of proteins
(PEGylation, Fc fusion, Genetic mutation, Novel single chain)
2.2.2 Hemophilia A: Late Stage Pipeline
a rFVIIIFc
b N8-GP
c BAY 94-9027
d CSL 627
e BAX 855
2.2.3 Hemophilia B: Late Stage Pipeline
a rFIXFc
b N9-GP
c CSL 654
2.3 Hemophilia with Inhibitors – Late Stage Pipeline
a BAY 86-6150
b CSL 689
c OBI-1
d BAX 817
e PF-05280602
f NecLip-rFVIIa
3. Novel Approaches for Hemophilia and Acquired Hemophilia
3.1 Gene Therapy
3.2 Tissue Factor Pathway Inhibitor (TFPI)
4. Biosimilar Development – A Safer Bet?
5. Market Forecast
5.1 Hemophilia A
5.2 Hemophilia B
5.3 Bypass Therapies – Hemophilia with Inhibitors
6. Current Marketed Therapies
6.1 FVIII Recombinants
a ADVATE
b Kogenate FS/ Helixate FS
c Xyntha
6.2 FIX Recombinants
a BeneFIX
6.3 Hemophilia with Inhibitors
6.3.1 Detection and Quantification
6.3.2
Treatment for Hemophilia with Inhibitors
(High-Dose Clotting Factor Concentrates, Bypassing Agents, Immune
Tolerance Induction – ITI Therapy)
6.3.3 Bypassing Agents
a NovoSeven / NovoSeven RT
b FEIBA
7. Cost of Treatment And Insurance
8. Hemophilia – About The Disease, Global Epidemiology, and
Acquired Hemophilia
8.1 Types of Hemophilia
8.2 Classification/ Severity of Disease
8.3 Acquired Hemophilia
8.4 Global Epidemiology
8.5 Mortality/Morbidity
8.6 Pathophysiology
8.7 Diagnosis
8.8 Treatment / Management
8.8.1 Prophylaxis
8.8.2 Episodic / On-Demand Therapy
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218460.
Contact sales@reportsandreports.com for further information.
Tuesday, 5 February 2013
Market Outlook of France Orthopedic Devices Industry to 2018– Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation
ReportsnReports adds new market research reports on "France Orthopedic Devices Market Outlook to 2018 – Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others" to its store.
GlobalData’s new report, “France Orthopedic Devices Market Outlook to 2018 – Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others” provides key market data on the France Orthopedic Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within twelve market categories – Trauma Fixation, Knee Reconstruction, Hip Reconstruction, Spinal Surgery, Arthroscopy, Orthopedic Braces and Supports, Orthobiologics, Cranio Maxillofacial Fixation (CMF), Other Joint Reconstruction, Orthopedic Bone Cement and Casting Materials, Orthopedic Tools and Orthopedic Prosthetics. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Orthopedic Devices market categories – Trauma Fixation, Knee Reconstruction, Hip Reconstruction, Spinal Surgery, Arthroscopy, Orthopedic Braces and Supports, Orthobiologics, Cranio Maxillofacial Fixation (CMF), Other Joint Reconstruction, Orthopedic Bone Cement and Casting Materials, Orthopedic Tools and Orthopedic Prosthetics.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within twelve market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the twelve market categories.
- Global corporate-level profiles of key companies operating within the France Orthopedic Devices market.
- Key players covered include DePuy, Inc, Zimmer Holdings, Inc., Stryker Corporation, Synthes, Inc., Smith & Nephew Plc, Biomet, Inc.and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the France Orthopedic Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=190175.
Published: August 2012
No. of Pages: 325
Price: Single User: US $ 2500 Corporate User: US $ 7500
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=190175.
1 Table of Contents
2 Introduction 22
3 Orthopedic Devices In France 23
4 Arthroscopy In France 36
5 Cranio Maxillofacial Fixation (CMF) In France 60
6 Hip Reconstruction In France 83
7 Knee Reconstruction In France 104
8 Orthobiologics In France 127
9 Orthopedic Bone Cement and Casting Materials In France 150
10 Orthopedic Braces and Supports In France 171
11 Orthopedic Prosthetics In France 186
12 Orthopedic Tools In France 195
13 Other Joint Reconstruction In France 208
14 Spinal Surgery In France 232
15 Trauma Fixation In France 261
16 Overview of Key Companies in France Orthopedic Devices Market 282
17 Orthopedic Devices Market Pipeline Products 298
18 Financial Deals Landscape 307
19 Recent Developments 308
20 Appendix 309
1.1 List of Tables
Contact sales@reportsandreports.com for further information.
GlobalData’s new report, “France Orthopedic Devices Market Outlook to 2018 – Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others” provides key market data on the France Orthopedic Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within twelve market categories – Trauma Fixation, Knee Reconstruction, Hip Reconstruction, Spinal Surgery, Arthroscopy, Orthopedic Braces and Supports, Orthobiologics, Cranio Maxillofacial Fixation (CMF), Other Joint Reconstruction, Orthopedic Bone Cement and Casting Materials, Orthopedic Tools and Orthopedic Prosthetics. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Orthopedic Devices market categories – Trauma Fixation, Knee Reconstruction, Hip Reconstruction, Spinal Surgery, Arthroscopy, Orthopedic Braces and Supports, Orthobiologics, Cranio Maxillofacial Fixation (CMF), Other Joint Reconstruction, Orthopedic Bone Cement and Casting Materials, Orthopedic Tools and Orthopedic Prosthetics.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within twelve market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the twelve market categories.
- Global corporate-level profiles of key companies operating within the France Orthopedic Devices market.
- Key players covered include DePuy, Inc, Zimmer Holdings, Inc., Stryker Corporation, Synthes, Inc., Smith & Nephew Plc, Biomet, Inc.and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the France Orthopedic Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=190175.
Published: August 2012
No. of Pages: 325
Price: Single User: US $ 2500 Corporate User: US $ 7500
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=190175.
1 Table of Contents
2 Introduction 22
3 Orthopedic Devices In France 23
4 Arthroscopy In France 36
5 Cranio Maxillofacial Fixation (CMF) In France 60
6 Hip Reconstruction In France 83
7 Knee Reconstruction In France 104
8 Orthobiologics In France 127
9 Orthopedic Bone Cement and Casting Materials In France 150
10 Orthopedic Braces and Supports In France 171
11 Orthopedic Prosthetics In France 186
12 Orthopedic Tools In France 195
13 Other Joint Reconstruction In France 208
14 Spinal Surgery In France 232
15 Trauma Fixation In France 261
16 Overview of Key Companies in France Orthopedic Devices Market 282
17 Orthopedic Devices Market Pipeline Products 298
18 Financial Deals Landscape 307
19 Recent Developments 308
20 Appendix 309
1.1 List of Tables
Contact sales@reportsandreports.com for further information.
Saturday, 2 February 2013
ReportsnReports: South Africa Ophthalmic devices Market Outlook to 2018
GlobalData’s new report, “South Africa Ophthalmic devices Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others” provides key market data on the South Africa Ophthalmic Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope of the report:
- Market size and company share data for Ophthalmic Devices market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the South Africa Ophthalmic Devicesmarket.
- Key players covered include Essilor International, Johnson & Johnson Vision Care, Inc., CooperVision, Inc., Hoya Corporation, CIBA Vision Corporation, Alcon, Inc. and others.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218185.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South Africa Ophthalmic Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218185.
1 Table of Contents
2 Introduction 15
3 Ophthalmic Devices In South Africa 16
4 Cataract Surgery Devices In South Africa 29
5 Glaucoma Surgery Devices In South Africa 47
6 Intraocular Lens (IOL) In South Africa 55
7 Ophthalmic Diagnostic Equipment In South Africa 73
8 Refractive Surgery Devices In South Africa 103
9 Vision Care In South Africa 122
10 Vitreo Retinal Surgery Devices In South Africa 154
11 Overview of Key Companies in South Africa Ophthalmic Devices Market 175
12 Ophthalmic Devices Market Pipeline Products 188
13 Financial Deals Landscape 191
14 Appendix 195
1.1 List of Tables
1.2 List of Figures
Contact sales@reportsandreports.com for further information.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope of the report:
- Market size and company share data for Ophthalmic Devices market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the South Africa Ophthalmic Devicesmarket.
- Key players covered include Essilor International, Johnson & Johnson Vision Care, Inc., CooperVision, Inc., Hoya Corporation, CIBA Vision Corporation, Alcon, Inc. and others.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218185.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South Africa Ophthalmic Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218185.
2 Introduction 15
3 Ophthalmic Devices In South Africa 16
4 Cataract Surgery Devices In South Africa 29
5 Glaucoma Surgery Devices In South Africa 47
6 Intraocular Lens (IOL) In South Africa 55
7 Ophthalmic Diagnostic Equipment In South Africa 73
8 Refractive Surgery Devices In South Africa 103
9 Vision Care In South Africa 122
10 Vitreo Retinal Surgery Devices In South Africa 154
11 Overview of Key Companies in South Africa Ophthalmic Devices Market 175
12 Ophthalmic Devices Market Pipeline Products 188
13 Financial Deals Landscape 191
14 Appendix 195
1.1 List of Tables
1.2 List of Figures
Contact sales@reportsandreports.com for further information.
Subscribe to:
Posts (Atom)